Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 163,889 | 71,410 | 83,079 | 39,482 | 74,983 |
| Depreciation Amortization | 37,774 | 32,881 | 1,239 | 192 | 92 |
| Income taxes - deferred | -9,388 | -17,818 | 4,937 | 9,316 | -32,971 |
| Accounts receivable | -11,962 | -43,075 | -3,820 | -632 | 4,549 |
| Accounts payable and accrued liabilities | 1,798 | 10,820 | 1,207 | -1,488 | 138 |
| Other Working Capital | 30,914 | -37,324 | 13,729 | 5,022 | -4,112 |
| Other Operating Activity | 26,783 | 126,706 | 15,676 | 8,480 | 2,355 |
| Operating Cash Flow | $239,808 | $143,600 | $116,047 | $60,372 | $45,034 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -10,000 | -10,000 |
| PPE Investments | -556 | -231 | -29 | -1,021 | -11 |
| Purchase Of Investment | N/A | -13,465 | N/A | N/A | 5,000 |
| Sale Of Investment | N/A | N/A | 19,238 | N/A | N/A |
| Other Investing Activity | 0 | -279,806 | -10,000 | 0 | 0 |
| Investing Cash Flow | $-556 | $-293,502 | $9,209 | $-11,021 | $-5,011 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 154,515 | 2,792 | 9,569 | 4,099 | 758 |
| Common Stock Repurchased | N/A | N/A | -6,907 | -12,089 | 0 |
| Other Financing Activity | -13,850 | -13,649 | -968 | -153 | -56 |
| Financing Cash Flow | $140,665 | $-10,857 | $1,694 | $-8,143 | $702 |
| Beginning Cash Position | 137,636 | 298,395 | 171,445 | 130,237 | 89,512 |
| End Cash Position | 517,553 | 137,636 | 298,395 | 171,445 | 130,237 |
| Net Cash Flow | $379,917 | $-160,759 | $126,950 | $41,208 | $40,725 |
| Free Cash Flow | |||||
| Operating Cash Flow | 239,808 | 143,600 | 116,047 | 60,372 | 45,034 |
| Capital Expenditure | -556 | -231 | -29 | -1,021 | -11 |
| Free Cash Flow | 239,252 | 143,369 | 116,018 | 59,351 | 45,023 |